Importantly, there is no official indication from NICE or the MHRA for using GLP-1 medications specifically for binge eating disorder
The treatment was well tolerated [47]
What works optimally for one person may require adjustment for another
What isn't established is that this translates into the dramatic, precisely-quantified superiority commonly claimed, and what's often left out entirely is that topical GHK-Cu, including our own 1% GHK-Cu Face and Skin Serum, has more, not less, human clinical evidence behind it, plus a regulated supply chain with verifiable manufacturing standards
Medicina (Kaunas, Lithuania), 59(7):1184
Standard dosing of 5001,000 mg every 46 hours (not exceeding 3,0004,000 mg daily) poses no known direct interaction with semaglutide's mechanism of action